nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitaxentan—CYP3A4—Temozolomide—malignant glioma	0.199	1	CbGbCtD
Sitaxentan—Partial seizures—Temozolomide—malignant glioma	0.0563	0.118	CcSEcCtD
Sitaxentan—Lung infection—Temozolomide—malignant glioma	0.0207	0.0433	CcSEcCtD
Sitaxentan—Pneumonia aspiration—Carmustine—malignant glioma	0.0161	0.0337	CcSEcCtD
Sitaxentan—Facial paralysis—Carmustine—malignant glioma	0.011	0.0231	CcSEcCtD
Sitaxentan—Skin necrosis—Carmustine—malignant glioma	0.0101	0.0211	CcSEcCtD
Sitaxentan—VIIth nerve paralysis—Carmustine—malignant glioma	0.00856	0.0179	CcSEcCtD
Sitaxentan—Tongue discolouration—Temozolomide—malignant glioma	0.00702	0.0147	CcSEcCtD
Sitaxentan—Faecal incontinence—Carmustine—malignant glioma	0.00696	0.0146	CcSEcCtD
Sitaxentan—Faecal incontinence—Temozolomide—malignant glioma	0.00672	0.0141	CcSEcCtD
Sitaxentan—Skin hyperpigmentation—Carmustine—malignant glioma	0.0059	0.0124	CcSEcCtD
Sitaxentan—Haemorrhoids—Temozolomide—malignant glioma	0.00577	0.0121	CcSEcCtD
Sitaxentan—Oral candidiasis—Carmustine—malignant glioma	0.00553	0.0116	CcSEcCtD
Sitaxentan—Oral candidiasis—Temozolomide—malignant glioma	0.00534	0.0112	CcSEcCtD
Sitaxentan—Cyst—Carmustine—malignant glioma	0.00525	0.011	CcSEcCtD
Sitaxentan—Vaginal haemorrhage—Temozolomide—malignant glioma	0.00459	0.00961	CcSEcCtD
Sitaxentan—Menorrhagia—Temozolomide—malignant glioma	0.00459	0.00961	CcSEcCtD
Sitaxentan—Herpes zoster—Temozolomide—malignant glioma	0.00451	0.00944	CcSEcCtD
Sitaxentan—Cholestasis—Temozolomide—malignant glioma	0.00447	0.00936	CcSEcCtD
Sitaxentan—Abscess—Carmustine—malignant glioma	0.00444	0.0093	CcSEcCtD
Sitaxentan—Otitis media—Temozolomide—malignant glioma	0.00436	0.00913	CcSEcCtD
Sitaxentan—Hyperaesthesia—Temozolomide—malignant glioma	0.00432	0.00906	CcSEcCtD
Sitaxentan—Memory impairment—Temozolomide—malignant glioma	0.00432	0.00906	CcSEcCtD
Sitaxentan—Petechiae—Temozolomide—malignant glioma	0.00412	0.00864	CcSEcCtD
Sitaxentan—Endocrine disorder—Temozolomide—malignant glioma	0.00409	0.00858	CcSEcCtD
Sitaxentan—Disturbance in attention—Temozolomide—malignant glioma	0.00392	0.00821	CcSEcCtD
Sitaxentan—Breast pain—Temozolomide—malignant glioma	0.00389	0.00815	CcSEcCtD
Sitaxentan—Amenorrhoea—Temozolomide—malignant glioma	0.00386	0.00809	CcSEcCtD
Sitaxentan—Thinking abnormal—Carmustine—malignant glioma	0.00384	0.00804	CcSEcCtD
Sitaxentan—Viral infection—Temozolomide—malignant glioma	0.00376	0.00787	CcSEcCtD
Sitaxentan—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00373	0.00782	CcSEcCtD
Sitaxentan—Herpes simplex—Temozolomide—malignant glioma	0.00368	0.00772	CcSEcCtD
Sitaxentan—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00359	0.00752	CcSEcCtD
Sitaxentan—Pulmonary embolism—Carmustine—malignant glioma	0.00351	0.00736	CcSEcCtD
Sitaxentan—Respiratory failure—Temozolomide—malignant glioma	0.00346	0.00724	CcSEcCtD
Sitaxentan—Musculoskeletal pain—Temozolomide—malignant glioma	0.00343	0.0072	CcSEcCtD
Sitaxentan—Pulmonary embolism—Temozolomide—malignant glioma	0.00339	0.00711	CcSEcCtD
Sitaxentan—Skin exfoliation—Carmustine—malignant glioma	0.00335	0.00703	CcSEcCtD
Sitaxentan—Candida infection—Carmustine—malignant glioma	0.00335	0.00703	CcSEcCtD
Sitaxentan—Skin exfoliation—Temozolomide—malignant glioma	0.00324	0.00679	CcSEcCtD
Sitaxentan—Candida infection—Temozolomide—malignant glioma	0.00324	0.00679	CcSEcCtD
Sitaxentan—Vaginal infection—Temozolomide—malignant glioma	0.0032	0.00671	CcSEcCtD
Sitaxentan—Neoplasm—Carmustine—malignant glioma	0.00318	0.00665	CcSEcCtD
Sitaxentan—Dry eye—Temozolomide—malignant glioma	0.00313	0.00657	CcSEcCtD
Sitaxentan—Neoplasm—Temozolomide—malignant glioma	0.00307	0.00643	CcSEcCtD
Sitaxentan—Mental disability—Carmustine—malignant glioma	0.00305	0.00639	CcSEcCtD
Sitaxentan—Mental disability—Temozolomide—malignant glioma	0.00294	0.00617	CcSEcCtD
Sitaxentan—Ear pain—Temozolomide—malignant glioma	0.00289	0.00605	CcSEcCtD
Sitaxentan—Gastroenteritis—Temozolomide—malignant glioma	0.00278	0.00582	CcSEcCtD
Sitaxentan—Deafness—Temozolomide—malignant glioma	0.00275	0.00577	CcSEcCtD
Sitaxentan—Hepatic failure—Temozolomide—malignant glioma	0.00274	0.00574	CcSEcCtD
Sitaxentan—Nasal congestion—Temozolomide—malignant glioma	0.0027	0.00567	CcSEcCtD
Sitaxentan—Menopausal symptoms—Temozolomide—malignant glioma	0.00261	0.00547	CcSEcCtD
Sitaxentan—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00255	0.00534	CcSEcCtD
Sitaxentan—Ataxia—Carmustine—malignant glioma	0.0024	0.00502	CcSEcCtD
Sitaxentan—Liver function test abnormal—Carmustine—malignant glioma	0.00235	0.00493	CcSEcCtD
Sitaxentan—Ataxia—Temozolomide—malignant glioma	0.00232	0.00485	CcSEcCtD
Sitaxentan—Dehydration—Temozolomide—malignant glioma	0.00229	0.0048	CcSEcCtD
Sitaxentan—Dry skin—Temozolomide—malignant glioma	0.00226	0.00473	CcSEcCtD
Sitaxentan—Muscular weakness—Carmustine—malignant glioma	0.00225	0.00471	CcSEcCtD
Sitaxentan—Breast disorder—Temozolomide—malignant glioma	0.00223	0.00467	CcSEcCtD
Sitaxentan—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00222	0.00465	CcSEcCtD
Sitaxentan—Muscular weakness—Temozolomide—malignant glioma	0.00217	0.00455	CcSEcCtD
Sitaxentan—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00217	0.00455	CcSEcCtD
Sitaxentan—Pancytopenia—Carmustine—malignant glioma	0.00209	0.00438	CcSEcCtD
Sitaxentan—Bronchitis—Temozolomide—malignant glioma	0.00205	0.00429	CcSEcCtD
Sitaxentan—Pancytopenia—Temozolomide—malignant glioma	0.00202	0.00424	CcSEcCtD
Sitaxentan—Dysuria—Temozolomide—malignant glioma	0.00199	0.00417	CcSEcCtD
Sitaxentan—Hyperglycaemia—Carmustine—malignant glioma	0.00199	0.00416	CcSEcCtD
Sitaxentan—Pollakiuria—Temozolomide—malignant glioma	0.00197	0.00412	CcSEcCtD
Sitaxentan—Photosensitivity reaction—Temozolomide—malignant glioma	0.00194	0.00407	CcSEcCtD
Sitaxentan—Renal failure—Carmustine—malignant glioma	0.00193	0.00405	CcSEcCtD
Sitaxentan—Weight decreased—Temozolomide—malignant glioma	0.00193	0.00404	CcSEcCtD
Sitaxentan—Hyperglycaemia—Temozolomide—malignant glioma	0.00192	0.00402	CcSEcCtD
Sitaxentan—Stomatitis—Carmustine—malignant glioma	0.00191	0.00401	CcSEcCtD
Sitaxentan—Infestation NOS—Temozolomide—malignant glioma	0.0019	0.00398	CcSEcCtD
Sitaxentan—Infestation—Temozolomide—malignant glioma	0.0019	0.00398	CcSEcCtD
Sitaxentan—Stomatitis—Temozolomide—malignant glioma	0.00185	0.00388	CcSEcCtD
Sitaxentan—Hepatobiliary disease—Temozolomide—malignant glioma	0.0018	0.00376	CcSEcCtD
Sitaxentan—Sinusitis—Temozolomide—malignant glioma	0.00178	0.00373	CcSEcCtD
Sitaxentan—Haemoglobin—Carmustine—malignant glioma	0.00177	0.00371	CcSEcCtD
Sitaxentan—Haemorrhage—Carmustine—malignant glioma	0.00176	0.0037	CcSEcCtD
Sitaxentan—Oedema peripheral—Carmustine—malignant glioma	0.00174	0.00364	CcSEcCtD
Sitaxentan—Haemoglobin—Temozolomide—malignant glioma	0.00171	0.00359	CcSEcCtD
Sitaxentan—Hepatitis—Temozolomide—malignant glioma	0.0017	0.00357	CcSEcCtD
Sitaxentan—Haemorrhage—Temozolomide—malignant glioma	0.0017	0.00357	CcSEcCtD
Sitaxentan—Visual impairment—Carmustine—malignant glioma	0.0017	0.00356	CcSEcCtD
Sitaxentan—Urinary tract disorder—Temozolomide—malignant glioma	0.00168	0.00353	CcSEcCtD
Sitaxentan—Oedema peripheral—Temozolomide—malignant glioma	0.00168	0.00352	CcSEcCtD
Sitaxentan—Urethral disorder—Temozolomide—malignant glioma	0.00167	0.0035	CcSEcCtD
Sitaxentan—Eye disorder—Carmustine—malignant glioma	0.00165	0.00345	CcSEcCtD
Sitaxentan—Visual impairment—Temozolomide—malignant glioma	0.00164	0.00344	CcSEcCtD
Sitaxentan—Flushing—Carmustine—malignant glioma	0.00164	0.00343	CcSEcCtD
Sitaxentan—Eye disorder—Temozolomide—malignant glioma	0.00159	0.00334	CcSEcCtD
Sitaxentan—Tinnitus—Temozolomide—malignant glioma	0.00159	0.00333	CcSEcCtD
Sitaxentan—Flushing—Temozolomide—malignant glioma	0.00158	0.00331	CcSEcCtD
Sitaxentan—Cardiac disorder—Temozolomide—malignant glioma	0.00158	0.00331	CcSEcCtD
Sitaxentan—Alopecia—Carmustine—malignant glioma	0.00156	0.00327	CcSEcCtD
Sitaxentan—Angiopathy—Temozolomide—malignant glioma	0.00155	0.00324	CcSEcCtD
Sitaxentan—Mental disorder—Carmustine—malignant glioma	0.00154	0.00324	CcSEcCtD
Sitaxentan—Immune system disorder—Temozolomide—malignant glioma	0.00154	0.00323	CcSEcCtD
Sitaxentan—Mediastinal disorder—Temozolomide—malignant glioma	0.00154	0.00322	CcSEcCtD
Sitaxentan—Malnutrition—Carmustine—malignant glioma	0.00154	0.00322	CcSEcCtD
Sitaxentan—Alopecia—Temozolomide—malignant glioma	0.00151	0.00316	CcSEcCtD
Sitaxentan—Mental disorder—Temozolomide—malignant glioma	0.00149	0.00313	CcSEcCtD
Sitaxentan—Malnutrition—Temozolomide—malignant glioma	0.00148	0.00311	CcSEcCtD
Sitaxentan—Tremor—Carmustine—malignant glioma	0.00144	0.00301	CcSEcCtD
Sitaxentan—Anaemia—Carmustine—malignant glioma	0.00142	0.00297	CcSEcCtD
Sitaxentan—Agitation—Carmustine—malignant glioma	0.00141	0.00296	CcSEcCtD
Sitaxentan—Tremor—Temozolomide—malignant glioma	0.00139	0.00291	CcSEcCtD
Sitaxentan—EDNRB—retina—malignant glioma	0.00138	0.155	CbGeAlD
Sitaxentan—Ill-defined disorder—Temozolomide—malignant glioma	0.00138	0.00288	CcSEcCtD
Sitaxentan—Leukopenia—Carmustine—malignant glioma	0.00137	0.00288	CcSEcCtD
Sitaxentan—Anaemia—Temozolomide—malignant glioma	0.00137	0.00287	CcSEcCtD
Sitaxentan—Agitation—Temozolomide—malignant glioma	0.00136	0.00286	CcSEcCtD
Sitaxentan—Malaise—Temozolomide—malignant glioma	0.00134	0.0028	CcSEcCtD
Sitaxentan—Vertigo—Temozolomide—malignant glioma	0.00133	0.00279	CcSEcCtD
Sitaxentan—Leukopenia—Temozolomide—malignant glioma	0.00133	0.00278	CcSEcCtD
Sitaxentan—Chest pain—Carmustine—malignant glioma	0.00131	0.00274	CcSEcCtD
Sitaxentan—EDNRB—telencephalon—malignant glioma	0.00127	0.142	CbGeAlD
Sitaxentan—Confusional state—Carmustine—malignant glioma	0.00126	0.00265	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00125	0.00263	CcSEcCtD
Sitaxentan—Oedema—Carmustine—malignant glioma	0.00125	0.00263	CcSEcCtD
Sitaxentan—Discomfort—Temozolomide—malignant glioma	0.00125	0.00262	CcSEcCtD
Sitaxentan—Infection—Carmustine—malignant glioma	0.00124	0.00261	CcSEcCtD
Sitaxentan—Dry mouth—Temozolomide—malignant glioma	0.00124	0.00259	CcSEcCtD
Sitaxentan—Thrombocytopenia—Carmustine—malignant glioma	0.00123	0.00257	CcSEcCtD
Sitaxentan—Tachycardia—Carmustine—malignant glioma	0.00122	0.00256	CcSEcCtD
Sitaxentan—Confusional state—Temozolomide—malignant glioma	0.00122	0.00256	CcSEcCtD
Sitaxentan—Oedema—Temozolomide—malignant glioma	0.00121	0.00254	CcSEcCtD
Sitaxentan—Infection—Temozolomide—malignant glioma	0.0012	0.00252	CcSEcCtD
Sitaxentan—Anorexia—Carmustine—malignant glioma	0.00119	0.0025	CcSEcCtD
Sitaxentan—Nervous system disorder—Temozolomide—malignant glioma	0.00119	0.00249	CcSEcCtD
Sitaxentan—Thrombocytopenia—Temozolomide—malignant glioma	0.00119	0.00248	CcSEcCtD
Sitaxentan—Skin disorder—Temozolomide—malignant glioma	0.00118	0.00246	CcSEcCtD
Sitaxentan—Hypotension—Carmustine—malignant glioma	0.00117	0.00245	CcSEcCtD
Sitaxentan—Anorexia—Temozolomide—malignant glioma	0.00115	0.00242	CcSEcCtD
Sitaxentan—Insomnia—Carmustine—malignant glioma	0.00113	0.00237	CcSEcCtD
Sitaxentan—Somnolence—Carmustine—malignant glioma	0.00111	0.00233	CcSEcCtD
Sitaxentan—Insomnia—Temozolomide—malignant glioma	0.0011	0.00229	CcSEcCtD
Sitaxentan—Decreased appetite—Carmustine—malignant glioma	0.00109	0.00228	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Carmustine—malignant glioma	0.00108	0.00227	CcSEcCtD
Sitaxentan—Somnolence—Temozolomide—malignant glioma	0.00108	0.00226	CcSEcCtD
Sitaxentan—Constipation—Carmustine—malignant glioma	0.00107	0.00225	CcSEcCtD
Sitaxentan—Pain—Carmustine—malignant glioma	0.00107	0.00225	CcSEcCtD
Sitaxentan—Dyspepsia—Temozolomide—malignant glioma	0.00107	0.00223	CcSEcCtD
Sitaxentan—Decreased appetite—Temozolomide—malignant glioma	0.00105	0.00221	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00105	0.00219	CcSEcCtD
Sitaxentan—Fatigue—Temozolomide—malignant glioma	0.00104	0.00219	CcSEcCtD
Sitaxentan—Pain—Temozolomide—malignant glioma	0.00104	0.00217	CcSEcCtD
Sitaxentan—Constipation—Temozolomide—malignant glioma	0.00104	0.00217	CcSEcCtD
Sitaxentan—Feeling abnormal—Carmustine—malignant glioma	0.00103	0.00216	CcSEcCtD
Sitaxentan—Feeling abnormal—Temozolomide—malignant glioma	0.000998	0.00209	CcSEcCtD
Sitaxentan—EDNRB—medulla oblongata—malignant glioma	0.000995	0.112	CbGeAlD
Sitaxentan—Body temperature increased—Carmustine—malignant glioma	0.00099	0.00208	CcSEcCtD
Sitaxentan—Urticaria—Temozolomide—malignant glioma	0.000962	0.00202	CcSEcCtD
Sitaxentan—Body temperature increased—Temozolomide—malignant glioma	0.000957	0.00201	CcSEcCtD
Sitaxentan—Hypersensitivity—Carmustine—malignant glioma	0.000923	0.00193	CcSEcCtD
Sitaxentan—EDNRB—midbrain—malignant glioma	0.000909	0.102	CbGeAlD
Sitaxentan—Asthenia—Carmustine—malignant glioma	0.000899	0.00188	CcSEcCtD
Sitaxentan—Hypersensitivity—Temozolomide—malignant glioma	0.000892	0.00187	CcSEcCtD
Sitaxentan—EDNRB—spinal cord—malignant glioma	0.000887	0.0996	CbGeAlD
Sitaxentan—Asthenia—Temozolomide—malignant glioma	0.000869	0.00182	CcSEcCtD
Sitaxentan—Diarrhoea—Carmustine—malignant glioma	0.000857	0.0018	CcSEcCtD
Sitaxentan—Dizziness—Carmustine—malignant glioma	0.000829	0.00174	CcSEcCtD
Sitaxentan—Diarrhoea—Temozolomide—malignant glioma	0.000828	0.00174	CcSEcCtD
Sitaxentan—EDNRA—medulla oblongata—malignant glioma	0.000822	0.0923	CbGeAlD
Sitaxentan—Dizziness—Temozolomide—malignant glioma	0.000801	0.00168	CcSEcCtD
Sitaxentan—Vomiting—Carmustine—malignant glioma	0.000797	0.00167	CcSEcCtD
Sitaxentan—Rash—Carmustine—malignant glioma	0.00079	0.00166	CcSEcCtD
Sitaxentan—Dermatitis—Carmustine—malignant glioma	0.000789	0.00165	CcSEcCtD
Sitaxentan—Headache—Carmustine—malignant glioma	0.000785	0.00164	CcSEcCtD
Sitaxentan—Vomiting—Temozolomide—malignant glioma	0.00077	0.00161	CcSEcCtD
Sitaxentan—Rash—Temozolomide—malignant glioma	0.000763	0.0016	CcSEcCtD
Sitaxentan—Dermatitis—Temozolomide—malignant glioma	0.000763	0.0016	CcSEcCtD
Sitaxentan—Headache—Temozolomide—malignant glioma	0.000759	0.00159	CcSEcCtD
Sitaxentan—EDNRA—midbrain—malignant glioma	0.000752	0.0844	CbGeAlD
Sitaxentan—Nausea—Carmustine—malignant glioma	0.000744	0.00156	CcSEcCtD
Sitaxentan—Nausea—Temozolomide—malignant glioma	0.000719	0.00151	CcSEcCtD
Sitaxentan—EDNRB—cerebellum—malignant glioma	0.000703	0.079	CbGeAlD
Sitaxentan—EDNRB—brain—malignant glioma	0.000571	0.0641	CbGeAlD
Sitaxentan—EDNRA—brain—malignant glioma	0.000472	0.053	CbGeAlD
Sitaxentan—EDNRB—Signaling by GPCR—PIK3CG—malignant glioma	0.000254	0.000805	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—PTPN11—malignant glioma	0.000249	0.000791	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—JAG2—malignant glioma	0.000249	0.000789	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—NOTCH2—malignant glioma	0.000248	0.000785	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—PIK3CD—malignant glioma	0.000246	0.000779	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—KNG1—malignant glioma	0.000242	0.000768	CbGpPWpGaD
Sitaxentan—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000241	0.000764	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—RTEL1—malignant glioma	0.000239	0.000758	CbGpPWpGaD
Sitaxentan—CYP2C9—Biological oxidations—GSTP1—malignant glioma	0.000237	0.00075	CbGpPWpGaD
Sitaxentan—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	0.000233	0.00074	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—AKT2—malignant glioma	0.000232	0.000736	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—NTRK1—malignant glioma	0.000231	0.000732	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000225	0.000714	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—PIK3CD—malignant glioma	0.000223	0.000707	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—MMP3—malignant glioma	0.000215	0.000681	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—PIK3CB—malignant glioma	0.000214	0.000679	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CDKN2B—malignant glioma	0.000213	0.000675	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000211	0.000669	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—H3F3A—malignant glioma	0.000211	0.000667	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—F2—malignant glioma	0.000209	0.000663	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CXCR3—malignant glioma	0.000208	0.000661	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—PTK2—malignant glioma	0.000207	0.000655	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—CXCL8—malignant glioma	0.000206	0.000652	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—HES1—malignant glioma	0.000203	0.000644	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NTRK2—malignant glioma	0.000203	0.000643	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—YWHAE—malignant glioma	0.000203	0.000643	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—NCOR1—malignant glioma	0.000202	0.00064	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—FLT1—malignant glioma	0.000202	0.00064	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—DUSP6—malignant glioma	0.000201	0.000637	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—PIK3CG—malignant glioma	0.0002	0.000634	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—RAF1—malignant glioma	0.000199	0.000632	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—JAG1—malignant glioma	0.000198	0.000629	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NOTCH3—malignant glioma	0.000198	0.000627	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—IL2—malignant glioma	0.000197	0.000624	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—PIK3CB—malignant glioma	0.000194	0.000617	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—FBXW7—malignant glioma	0.000194	0.000616	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—PDGFRA—malignant glioma	0.000193	0.000613	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—BDKRB2—malignant glioma	0.000191	0.000605	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—F2—malignant glioma	0.00019	0.000602	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—SPP1—malignant glioma	0.000188	0.000595	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000187	0.000594	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—CXCL8—malignant glioma	0.000187	0.000593	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—AKT2—malignant glioma	0.000183	0.00058	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—PIK3CG—malignant glioma	0.000182	0.000576	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000181	0.000575	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—IL2—malignant glioma	0.000179	0.000566	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—PTPN11—malignant glioma	0.000178	0.000566	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—TERT—malignant glioma	0.000178	0.000564	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NOTCH2—malignant glioma	0.000177	0.000562	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—PIK3CD—malignant glioma	0.000176	0.000557	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—PDGFB—malignant glioma	0.000174	0.000551	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—KNG1—malignant glioma	0.000173	0.00055	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—FGFR1—malignant glioma	0.000173	0.000548	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000171	0.000542	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—HIF1A—malignant glioma	0.00017	0.00054	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—AKT2—malignant glioma	0.000166	0.000527	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000165	0.000524	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NTRK1—malignant glioma	0.000165	0.000524	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CAV1—malignant glioma	0.000165	0.000522	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—KDR—malignant glioma	0.000163	0.000516	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—PIK3CD—malignant glioma	0.00016	0.000506	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000158	0.0005	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—F2—malignant glioma	0.000157	0.000497	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—FN1—malignant glioma	0.000157	0.000497	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000156	0.000495	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—BAD—malignant glioma	0.000155	0.000491	CbGpPWpGaD
Sitaxentan—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.000154	0.000488	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MMP3—malignant glioma	0.000154	0.000487	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—NOTCH1—malignant glioma	0.000153	0.000486	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—PIK3CB—malignant glioma	0.000153	0.000486	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CDKN2B—malignant glioma	0.000152	0.000483	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—COX8A—malignant glioma	0.000151	0.000478	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CD80—malignant glioma	0.00015	0.000476	CbGpPWpGaD
Sitaxentan—CYP3A4—central nervous system—malignant glioma	0.00015	0.0169	CbGeAlD
Sitaxentan—EDNRB—Signaling Pathways—PIK3CG—malignant glioma	0.00015	0.000475	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—APC—malignant glioma	0.00015	0.000475	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—EGF—malignant glioma	0.000148	0.00047	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PTK2—malignant glioma	0.000148	0.000469	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—PTPN11—malignant glioma	0.000147	0.000467	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—CXCL8—malignant glioma	0.000147	0.000467	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—HES1—malignant glioma	0.000145	0.000461	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NCOR1—malignant glioma	0.000145	0.000458	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—RAF1—malignant glioma	0.000143	0.000452	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—BRAF—malignant glioma	0.000141	0.000447	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—IL2—malignant glioma	0.000141	0.000446	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—PIK3CB—malignant glioma	0.000139	0.000441	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PDGFRA—malignant glioma	0.000138	0.000439	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—COX8A—malignant glioma	0.000137	0.000436	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—AKT2—malignant glioma	0.000137	0.000435	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—EGFR—malignant glioma	0.000137	0.000433	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000135	0.000427	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—SPP1—malignant glioma	0.000134	0.000426	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—CXCL8—malignant glioma	0.000134	0.000424	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—PIK3CD—malignant glioma	0.000132	0.000418	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—PIK3CA—malignant glioma	0.000131	0.000414	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—KRAS—malignant glioma	0.000129	0.000409	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ASMT—malignant glioma	0.000128	0.000406	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—IL2—malignant glioma	0.000128	0.000405	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—TERT—malignant glioma	0.000127	0.000404	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—FGF2—malignant glioma	0.000126	0.0004	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000125	0.000397	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PDGFB—malignant glioma	0.000124	0.000394	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—FGFR1—malignant glioma	0.000124	0.000392	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000123	0.000389	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—HIF1A—malignant glioma	0.000122	0.000386	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—BCAN—malignant glioma	0.00012	0.000382	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—PIK3CA—malignant glioma	0.000119	0.000376	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—MDM2—malignant glioma	0.000118	0.000374	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CAV1—malignant glioma	0.000118	0.000373	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—RAF1—malignant glioma	0.000118	0.000373	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ASMT—malignant glioma	0.000117	0.00037	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—KDR—malignant glioma	0.000116	0.000369	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—ERBB2—malignant glioma	0.000116	0.000369	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—PIK3CB—malignant glioma	0.000115	0.000364	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000114	0.000362	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—FN1—malignant glioma	0.000112	0.000355	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—F2—malignant glioma	0.000112	0.000355	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—BAD—malignant glioma	0.000111	0.000351	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CXCL8—malignant glioma	0.00011	0.00035	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—BCAN—malignant glioma	0.00011	0.000348	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NOTCH1—malignant glioma	0.00011	0.000348	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CD80—malignant glioma	0.000107	0.000341	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PIK3CG—malignant glioma	0.000107	0.00034	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—APC—malignant glioma	0.000107	0.00034	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—AKT1—malignant glioma	0.000107	0.000338	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—EGF—malignant glioma	0.000106	0.000336	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CASP3—malignant glioma	0.000106	0.000335	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IL2—malignant glioma	0.000106	0.000335	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PTPN11—malignant glioma	0.000105	0.000334	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—BRAF—malignant glioma	0.000101	0.00032	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—MMP9—malignant glioma	9.99e-05	0.000317	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—PTEN—malignant glioma	9.93e-05	0.000315	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—AKT2—malignant glioma	9.82e-05	0.000311	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—EGFR—malignant glioma	9.78e-05	0.00031	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—IDH2—malignant glioma	9.71e-05	0.000308	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—AKT1—malignant glioma	9.68e-05	0.000307	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PIK3CD—malignant glioma	9.43e-05	0.000299	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—PIK3CA—malignant glioma	9.34e-05	0.000296	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—KRAS—malignant glioma	9.24e-05	0.000293	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	9.16e-05	0.00029	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CYP2B6—malignant glioma	9.13e-05	0.000289	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—COX8A—malignant glioma	9.06e-05	0.000287	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—FGF2—malignant glioma	9.03e-05	0.000286	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—VEGFA—malignant glioma	8.97e-05	0.000284	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—STAT3—malignant glioma	8.88e-05	0.000281	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—IDH2—malignant glioma	8.85e-05	0.000281	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—PIK3CA—malignant glioma	8.48e-05	0.000269	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MDM2—malignant glioma	8.45e-05	0.000268	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—RAF1—malignant glioma	8.42e-05	0.000267	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—IDH1—malignant glioma	8.35e-05	0.000265	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	8.35e-05	0.000265	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—ERBB2—malignant glioma	8.33e-05	0.000264	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CYP2B6—malignant glioma	8.32e-05	0.000264	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—MYC—malignant glioma	8.25e-05	0.000262	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PIK3CB—malignant glioma	8.22e-05	0.000261	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—SPHK1—malignant glioma	8.08e-05	0.000256	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—EGFR—malignant glioma	8.07e-05	0.000256	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CYP2C18—malignant glioma	7.92e-05	0.000251	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CXCL8—malignant glioma	7.9e-05	0.000251	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ASMT—malignant glioma	7.7e-05	0.000244	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—AKT1—malignant glioma	7.63e-05	0.000242	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—KRAS—malignant glioma	7.62e-05	0.000242	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—IDH1—malignant glioma	7.61e-05	0.000241	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CASP3—malignant glioma	7.56e-05	0.00024	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IL2—malignant glioma	7.55e-05	0.000239	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	7.46e-05	0.000237	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—SPHK1—malignant glioma	7.37e-05	0.000234	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—BCAN—malignant glioma	7.24e-05	0.00023	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CYP2C18—malignant glioma	7.22e-05	0.000229	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MMP9—malignant glioma	7.15e-05	0.000227	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PTEN—malignant glioma	7.1e-05	0.000225	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—PIK3CA—malignant glioma	7e-05	0.000222	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—AKT1—malignant glioma	6.93e-05	0.00022	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	6.81e-05	0.000216	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	6.8e-05	0.000216	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—TP53—malignant glioma	6.78e-05	0.000215	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	6.56e-05	0.000208	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—VEGFA—malignant glioma	6.42e-05	0.000203	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GSTT1—malignant glioma	6.4e-05	0.000203	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—STAT3—malignant glioma	6.35e-05	0.000201	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	6.2e-05	0.000197	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PTGS1—malignant glioma	6e-05	0.00019	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	5.98e-05	0.00019	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	5.98e-05	0.000189	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MYC—malignant glioma	5.9e-05	0.000187	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—IDH2—malignant glioma	5.84e-05	0.000185	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GSTT1—malignant glioma	5.84e-05	0.000185	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—EGFR—malignant glioma	5.78e-05	0.000183	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—AKT1—malignant glioma	5.72e-05	0.000181	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—BCHE—malignant glioma	5.58e-05	0.000177	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—SLC5A5—malignant glioma	5.51e-05	0.000175	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CYP2B6—malignant glioma	5.49e-05	0.000174	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PTGS1—malignant glioma	5.47e-05	0.000173	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—KRAS—malignant glioma	5.46e-05	0.000173	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	5.45e-05	0.000173	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	5.21e-05	0.000165	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	5.16e-05	0.000164	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—BCHE—malignant glioma	5.09e-05	0.000161	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—SLC5A5—malignant glioma	5.02e-05	0.000159	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—IDH1—malignant glioma	5.02e-05	0.000159	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PIK3CA—malignant glioma	5.01e-05	0.000159	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—SPHK1—malignant glioma	4.86e-05	0.000154	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—TP53—malignant glioma	4.85e-05	0.000154	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CYP2C18—malignant glioma	4.76e-05	0.000151	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.75e-05	0.000151	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.71e-05	0.000149	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.5e-05	0.000143	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GSTP1—malignant glioma	4.44e-05	0.000141	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CAT—malignant glioma	4.32e-05	0.000137	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.1e-05	0.00013	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—AKT1—malignant glioma	4.09e-05	0.00013	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—NCOR1—malignant glioma	4.08e-05	0.000129	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GSTP1—malignant glioma	4.05e-05	0.000128	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CAT—malignant glioma	3.94e-05	0.000125	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GSTT1—malignant glioma	3.85e-05	0.000122	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—NCOR1—malignant glioma	3.72e-05	0.000118	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PTGS1—malignant glioma	3.61e-05	0.000114	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—BCHE—malignant glioma	3.35e-05	0.000106	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CAV1—malignant glioma	3.32e-05	0.000105	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—SLC5A5—malignant glioma	3.31e-05	0.000105	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.18e-05	0.000101	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CAV1—malignant glioma	3.03e-05	9.61e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PIK3CG—malignant glioma	3.03e-05	9.6e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PPARG—malignant glioma	2.92e-05	9.27e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.9e-05	9.18e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PIK3CG—malignant glioma	2.76e-05	8.75e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GSTP1—malignant glioma	2.67e-05	8.46e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PPARG—malignant glioma	2.66e-05	8.45e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PIK3CD—malignant glioma	2.66e-05	8.44e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CAT—malignant glioma	2.6e-05	8.23e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—NCOR1—malignant glioma	2.45e-05	7.77e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PIK3CD—malignant glioma	2.43e-05	7.69e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PIK3CB—malignant glioma	2.32e-05	7.36e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PTGS2—malignant glioma	2.3e-05	7.29e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PIK3CB—malignant glioma	2.12e-05	6.71e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PTGS2—malignant glioma	2.1e-05	6.65e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PTEN—malignant glioma	2e-05	6.36e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CAV1—malignant glioma	2e-05	6.34e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PTEN—malignant glioma	1.83e-05	5.8e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.82e-05	5.77e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PPARG—malignant glioma	1.76e-05	5.57e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.6e-05	5.07e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PIK3CA—malignant glioma	1.41e-05	4.48e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.4e-05	4.42e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PTGS2—malignant glioma	1.38e-05	4.38e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PIK3CA—malignant glioma	1.29e-05	4.09e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PTEN—malignant glioma	1.21e-05	3.82e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—AKT1—malignant glioma	1.16e-05	3.66e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—AKT1—malignant glioma	1.05e-05	3.34e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PIK3CA—malignant glioma	8.51e-06	2.7e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—AKT1—malignant glioma	6.95e-06	2.2e-05	CbGpPWpGaD
